Charles River Associates (CRA) Announces Third Quarter 2013 Financial Results
Broad-Based Revenue Growth Drives Improved Results
Revenue for the third quarter of fiscal 2013 was
Net income for the third quarter of fiscal 2013 was
The Adjusted EBITDA for the third quarter of fiscal 2013 was
A complete reconciliation between revenue, net income/loss and net income/loss per diluted share, and the calculation of Adjusted EBITDA, on a GAAP and non-GAAP basis, for the third quarters of fiscal 2013 and fiscal 2012 is provided in the financial tables at the end of this release.
Management Comments
“We are pleased with the broad-based performance improvement across our portfolio during the third quarter of fiscal 2013,” said
“We remain focused on leveraging our infrastructure. For the third quarter of fiscal 2013, non-GAAP SG&A expenses, after adjusting for commissions to non-employee experts, decreased to 17.6% of revenue compared with 21.4% for the third quarter of the last fiscal year. We believe there is opportunity to further improve margins as we grow our top line.”
Outlook
“Throughout most of 2013, we experienced healthy lead flow and strong project conversions, and we began to realize dividends from these activities during the third quarter. We expect this trend to continue across our
Conference Call Information and Prepared CFO Remarks
CRA will host a conference call this morning at
In combination with this press release, CRA is providing prepared remarks by its CFO
About
Charles River Associates® is a global consulting firm specializing in litigation, regulatory, and financial consulting, and management consulting. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Detailed information about
NON-GAAP FINANCIAL MEASURES
In addition to reporting its financial results in accordance with U.S. generally accepted accounting principles, or GAAP, the Company has also provided in this release non-GAAP financial information. The Company believes the use of non-GAAP measures in addition to GAAP measures is an additional useful method of evaluating its results of operations. The Company believes that presenting its financial results excluding certain restructuring costs, certain non-cash expenses, and the results of the Company’s NeuCo subsidiary is important to investors and management because it is more indicative of the Company’s ongoing operating results and financial condition. These non-GAAP financial measures should be considered in conjunction with, but not as a substitute for, the financial information presented in accordance with GAAP, and the expected results calculated in accordance with GAAP and reconciliations to those expected results should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. Specifically, for the third quarter of fiscal 2013, the Company has excluded NeuCo’s results, and for the third quarter of fiscal 2012, the Company has excluded certain restructuring costs and NeuCo’s results. Also, in calculating “Adjusted EBITDA,” the Company has excluded the following non-cash expenses: depreciation and amortization, share-based compensation expenses, and amortization of forgivable loans.
Statements in this press release concerning the future business, operating results and financial condition of the Company, and statements using the terms “believes,” “expects,” “should,” “prospects,” “remain encouraged,” “opportunities,” or similar expressions are “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based upon management's current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual performance or results to differ materially from any forward-looking statements made by the Company include, among others, the Company’s restructuring costs and attributable annual cost savings, changes in the Company’s effective tax rate, share dilution from the Company’s stock-based compensation, dependence on key personnel, attracting, recruiting and retaining qualified consultants, dependence on outside experts, utilization rates, completing acquisitions and factors related to its completed acquisitions, including integration of personnel, clients and offices, and unanticipated expenses and liabilities, the risk of impairment write downs to the Company’s intangible assets, including goodwill, if the Company’s enterprise value declines below certain levels, risks associated with acquisitions it may make in the future, risks inherent in international operations, the performance of NeuCo, changes in accounting standards, rules and regulations, changes in the law that affect the Company’s practice areas, management of new offices, the potential loss of clients, the ability of customers to terminate the Company’s engagements on short notice, dependence on the growth of the Company’s management consulting practice, the unpredictable nature of litigation-related projects, the ability of the Company to integrate successfully new consultants into its practice, the Company’s ability to collect on forgivable loans should any become due, general economic conditions, intense competition, risks inherent in litigation, and professional liability. Further information on these and other potential factors that could affect the Company’s financial results is included in the Company’s periodic filings with the
CRA INTERNATIONAL, INC. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS INCLUDING A RECONCILIATION TO NON-GAAP RESULTS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
FOR THE FISCAL QUARTER ENDED SEPTEMBER 28, 2013 COMPARED TO THE FISCAL QUARTER ENDED SEPTEMBER 29, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except per share data) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarter Ended September 28, 2013 | Quarter Ended September 29, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP | Adjustments to | Non-GAAP | GAAP | Adjustments to | Adjustments to | Non-GAAP | |||||||||||||||||||||||||||||||||||||||||||||||||
GAAP | % of | GAAP Results | Non-GAAP | % of | GAAP | % of | GAAP Results | GAAP Results | Non-GAAP | % of | |||||||||||||||||||||||||||||||||||||||||||||
Results | Revenues | (NeuCo) (1) | Results | Revenues | Results | Revenues | (Restructuring) (2) | (NeuCo) (1) | Results | Revenues | |||||||||||||||||||||||||||||||||||||||||||||
Revenues | $ | 74,427 | 100.0 | % | $ | 1,481 | $ | 72,946 | 100.0 | % | $ | 65,912 | 100.0 | % | $ | - | $ | 1,242 | $ | 64,670 | 100.0 | % | |||||||||||||||||||||||||||||||||
Costs of services | 50,577 | 68.0 | % | 357 | 50,220 | 68.8 | % | 46,175 | 70.1 | % | 3,435 | 311 | 42,429 | 65.6 | % | ||||||||||||||||||||||||||||||||||||||||
Gross profit (loss) | 23,850 | 32.0 | % | 1,124 | 22,726 | 31.2 | % | 19,737 | 29.9 | % | (3,435 | ) | 931 | 22,241 | 34.4 | % | |||||||||||||||||||||||||||||||||||||||
Selling, general and administrative expenses | 16,096 | 21.6 | % | 892 | 15,204 | 20.8 | % | 17,227 | 26.1 | % | 960 | 709 | 15,558 | 24.1 | % | ||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization | 1,640 | 2.2 | % | 1 | 1,639 | 2.2 | % | 1,475 | 2.2 | % | 29 | 1 | 1,445 | 2.2 | % | ||||||||||||||||||||||||||||||||||||||||
Income (loss) from operations | 6,114 | 8.2 | % | 231 | 5,883 | 8.1 | % | 1,035 | 1.6 | % | (4,424 | ) | 221 | 5,238 | 8.1 | % | |||||||||||||||||||||||||||||||||||||||
Interest and other income (expense), net | (162 | ) | -0.2 | % | (36 | ) | (126 | ) | -0.2 | % | (19 | ) | 0.0 | % | - | (35 | ) | 16 | 0.0 | % | |||||||||||||||||||||||||||||||||||
Income (loss) before (provision) benefit for income taxes and noncontrolling interest |
5,952 | 8.0 | % | 195 | 5,757 | 7.9 | % | 1,016 | 1.5 | % | (4,424 | ) | 186 | 5,254 | 8.1 | % | |||||||||||||||||||||||||||||||||||||||
(Provision) benefit for income taxes | (2,619 | ) | -3.5 | % | (51 | ) | (2,568 | ) | -3.5 | % | (1,722 | ) | -2.6 | % | 825 | (43 | ) | (2,504 | ) | -3.9 | % | ||||||||||||||||||||||||||||||||||
Net income (loss) | 3,333 | 4.5 | % | 144 | 3,189 | 4.4 | % | (706 | ) | -1.1 | % | (3,599 | ) | 143 | 2,750 | 4.3 | % | ||||||||||||||||||||||||||||||||||||||
Net (income) loss attributable to noncontrolling interest, net of tax | (63 | ) | -0.1 | % | (63 | ) | - | 0.0 | % | (38 | ) | -0.1 | % | - | (38 | ) | - | 0.0 | % | ||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to CRA International, Inc. | $ | 3,270 | 4.4 | % | $ | 81 | $ | 3,189 | 4.4 | % | $ | (744 | ) | -1.1 | % | $ | (3,599 | ) | $ | 105 | $ | 2,750 | 4.3 | % | |||||||||||||||||||||||||||||||
Net income (loss) per share attributable to CRA International, Inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic | $ | 0.32 | $ | 0.32 | $ | (0.07 | ) | $ | 0.27 | ||||||||||||||||||||||||||||||||||||||||||||||
Diluted | $ | 0.32 | $ | 0.31 | $ | (0.07 | ) | $ | 0.27 | ||||||||||||||||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic | 10,093 | 10,093 | 10,084 | 10,084 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Diluted | 10,192 | 10,192 | 10,084 | (3 | ) | 10,214 |
|
(3) |
|||||||||||||||||||||||||||||||||||||||||||||||
(1) These adjustments include activity related to NeuCo in the Company's GAAP results. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
(2) During the fiscal quarter ended September 29, 2012, the Company incurred pre-tax expenses of $4.4 million and related income tax benefit of $0.8 million principally associated with restructuring actions announced in the third quarter of fiscal 2012. These actions included the elimination and restructuring of selected practice areas, and reducing selling, general and administrative costs. In connection with the restructuring plan, the Company eliminated its Chemicals practice and closed its Middle East operations. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
(3) Approximately 130,000 common stock equivalents were excluded from the GAAP results because they were antidilutive in the third quarter of fiscal 2012 due to the net loss, but they were included in the non-GAAP results because they were dilutive based upon the net income. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
CRA INTERNATIONAL, INC. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS INCLUDING A RECONCILIATION TO NON-GAAP RESULTS | |||||||||||||||||||||||||||||||||||||||||||||||||||||
FOR THE FISCAL YEAR TO DATE PERIOD ENDED SEPTEMBER 28, 2013 COMPARED TO THE FISCAL YEAR TO DATE PERIOD ENDED SEPTEMBER 29, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except per share data) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Year To Date Period Ended September 28, 2013 |
Year To Date Period Ended September 29, 2012 |
||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP | Adjustments to | Non-GAAP | GAAP | Adjustments to | Adjustments to | Non-GAAP | |||||||||||||||||||||||||||||||||||||||||||||||
GAAP | % of | GAAP Results | Non-GAAP | % of | GAAP | % of | GAAP Results | GAAP Results | Non-GAAP | % of | |||||||||||||||||||||||||||||||||||||||||||
Results | Revenues | (NeuCo) (1) | Results | Revenues | Results | Revenues | (Restructuring) (2) | (NeuCo) (1) | Results | Revenues | |||||||||||||||||||||||||||||||||||||||||||
Revenues | $ | 202,760 | 100.0 | % | $ | 3,703 | $ | 199,057 | 100.0 | % | $ | 202,857 | 100.0 | % | $ | - | $ | 3,914 | $ | 198,943 | 100.0 | % | |||||||||||||||||||||||||||||||
Costs of services | 137,634 | 67.9 | % | 1,026 | 136,608 | 68.6 | % | 138,110 | 68.1 | % | 3,435 | 993 | 133,682 | 67.2 | % | ||||||||||||||||||||||||||||||||||||||
Gross profit (loss) | 65,126 | 32.1 | % | 2,677 | 62,449 | 31.4 | % | 64,747 | 31.9 | % | (3,435 | ) | 2,921 | 65,261 | 32.8 | % | |||||||||||||||||||||||||||||||||||||
Selling, general and administrative expenses | 47,276 | 23.3 | % | 2,666 | 44,610 | 22.4 | % | 52,018 | 25.6 | % | 1,731 | 2,512 | 47,775 | 24.0 | % | ||||||||||||||||||||||||||||||||||||||
Depreciation and amortization | 4,792 | 2.4 | % | 3 | 4,789 | 2.4 | % | 5,580 | 2.8 | % | 1,174 | 3 | 4,403 | 2.2 | % | ||||||||||||||||||||||||||||||||||||||
Income (loss) from operations | 13,058 | 6.4 | % | 8 | 13,050 | 6.6 | % | 7,149 | 3.5 | % | (6,340 | ) | 406 | 13,083 | 6.6 | % | |||||||||||||||||||||||||||||||||||||
Interest and other income (expense), net | (361 | ) | -0.2 | % | (70 | ) | (291 | ) | -0.1 | % | (185 | ) | -0.1 | % | - | (117 | ) | (68 | ) | 0.0 | % | ||||||||||||||||||||||||||||||||
Income (loss) before (provision) benefit for income taxes and noncontrolling interest |
12,697 | 6.3 | % | (62 | ) | 12,759 | 6.4 | % | 6,964 | 3.4 | % | (6,340 | ) | 289 | 13,015 | 6.5 | % | ||||||||||||||||||||||||||||||||||||
(Provision) benefit for income taxes | (5,178 | ) | -2.6 | % | (181 | ) | (4,997 | ) | -2.5 | % | (6,461 | ) | -3.2 | % | 869 | (98 | ) | (7,232 | ) | -3.6 | % | ||||||||||||||||||||||||||||||||
Net income (loss) | 7,519 | 3.7 | % | (243 | ) | 7,762 | 3.9 | % | 503 | 0.2 | % | (5,471 | ) | 191 | 5,783 | 2.9 | % | ||||||||||||||||||||||||||||||||||||
Net (income) loss attributable to noncontrolling interest, net of tax | 129 | 0.1 | % | 129 | - | 0.0 | % | (9 | ) | 0.0 | % | - | (9 | ) | - | 0.0 | % | ||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to CRA International, Inc. | $ | 7,648 | 3.8 | % | $ | (114 | ) | $ | 7,762 | 3.9 | % | $ | 494 | 0.2 | % | $ | (5,471 | ) | $ | 182 | $ | 5,783 | 2.9 | % | |||||||||||||||||||||||||||||
Net income per share attributable to CRA International, Inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic | $ | 0.76 | $ | 0.77 | $ | 0.05 | $ | 0.57 | |||||||||||||||||||||||||||||||||||||||||||||
Diluted | $ | 0.75 | $ | 0.76 | $ | 0.05 | $ | 0.56 | |||||||||||||||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic | 10,088 | 10,088 | 10,214 | 10,214 | |||||||||||||||||||||||||||||||||||||||||||||||||
Diluted | 10,180 | 10,180 | 10,364 | 10,364 | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
(1) These adjustments include activity related to NeuCo in the Company's GAAP results. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(2) During the fiscal year to date period ended September 29, 2012, the Company incurred pre-tax expenses of $6.3 million and related income tax benefit of $0.9 million principally associated with restructuring actions announced in the third quarter of fiscal 2012. Of these amounts, $4.4 million of pre-tax expenses and $0.8 million of related income tax benefit were in connection with restructuring activities announced during the third quarter of fiscal 2012. These actions included the elimination and restructuring of selected practice areas, and reducing selling, general and administrative costs. In connection with the restructuring plan, the Company eliminated its Chemicals practice and closed its Middle East operations. In the first half of fiscal 2012, the Company also incurred pre-tax expenses of $1.9 million and related income tax provision of $44,000 in connection with the surrender of a portion of the Company's leased office space in London, England and adjustments related to its leased office space in Houston, TX. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
CRA INTERNATIONAL, INC. | |||||||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
(In thousands) | |||||||||
September 28, | December 29, | ||||||||
2013 | 2012 | ||||||||
Assets | |||||||||
Cash and cash equivalents | $ | 17,902 | $ | 55,451 | |||||
Accounts receivable and unbilled, net | 96,675 | 77,270 | |||||||
Other current assets | 27,955 | 38,956 | |||||||
Total current assets | 142,532 | 171,677 | |||||||
Property and equipment, net | 16,609 | 17,980 | |||||||
Goodwill and intangible assets, net | 80,865 | 72,599 | |||||||
Other assets | 59,351 | 29,754 | |||||||
Total assets | $ | 299,357 | $ | 292,010 | |||||
Liabilities and shareholders’ equity | |||||||||
Current liabilities | $ | 70,848 | $ | 69,210 | |||||
Long-term liabilities | 6,926 | 10,566 | |||||||
Total liabilities | 77,774 | 79,776 | |||||||
Total shareholders’ equity | 221,583 | 212,234 | |||||||
Total liabilities and shareholders’ equity | $ | 299,357 | $ | 292,010 | |||||
CRA INTERNATIONAL, INC. | |||||||||||||||||||||||||||||||||||||||||||||||
UNAUDITED ADJUSTED EBITDA INCLUDING A RECONCILIATION TO NON-GAAP ADJUSTED EBITDA | |||||||||||||||||||||||||||||||||||||||||||||||
FOR THE QUARTER AND YEAR TO DATE PERIOD ENDED SEPTEMBER 28, 2013 COMPARED TO THE QUARTER AND YEAR TO DATE PERIOD ENDED SEPTEMBER 29, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
Quarter Ended September 28, 2013 | Quarter Ended September 29, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||
GAAP | GAAP | Adjustments to | Non-GAAP | Non-GAAP | GAAP | GAAP | Adjustments to | Adjustments to | Non-GAAP | Non-GAAP | |||||||||||||||||||||||||||||||||||||
Quarter Ended | % of | GAAP Results | Quarter Ended | % of | Quarter Ended | % of | GAAP Results | GAAP Results | Quarter Ended | % of | |||||||||||||||||||||||||||||||||||||
September 28, 2013 | Revenues | NeuCo (1) | September 28, 2013 | Revenues | September 29, 2012 | Revenues | Restructuring (2) | NeuCo (1) | September 29, 2012 | Revenues | |||||||||||||||||||||||||||||||||||||
Income (loss) from operations | $ | 6,114 | 8.2 | % | $ | 231 | $ | 5,883 | 8.1 | % | $ | 1,035 | 1.6 | % | $ | (4,424 | ) | $ | 221 | $ | 5,238 | 8.1 | % | ||||||||||||||||||||||||
Depreciation and amortization | 1,640 | 2.2 | % | 1 | 1,639 | 2.2 | % | 1,475 | 2.2 | % | 29 | 1 | 1,445 | 2.2 | % | ||||||||||||||||||||||||||||||||
EBITDA | 7,754 | 10.4 | % | 232 | 7,522 | 10.3 | % | 2,510 | 3.8 | % | (4,395 | ) | 222 | 6,683 | 10.3 | % | |||||||||||||||||||||||||||||||
Share-based compensation expenses | 832 | 1.1 | % | - | 832 | 1.1 | % | 1,311 | 2.0 | % | - | - | 1,311 | 2.0 | % | ||||||||||||||||||||||||||||||||
Amortization of forgivable loans | 3,805 | 5.1 | % | - | 3,805 | 5.2 | % | 1,569 | 2.4 | % | - | - | 1,569 | 2.4 | % | ||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 12,391 | 16.6 | % | $ | 232 | $ | 12,159 | 16.7 | % | $ | 5,390 | 8.2 | % | $ | (4,395 | ) | $ | 222 | $ | 9,563 | 14.8 | % | ||||||||||||||||||||||||
Year to Date Period Ended September 28, 2013 | Year to Date Period Ended September 29, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | ||||||||||||||||||||||||||||||||||||||||||||
Year to Date | GAAP | Adjustments to | Year to Date | Non-GAAP | Year to Date | GAAP | Adjustments to | Adjustments to | Year to Date | Non-GAAP | |||||||||||||||||||||||||||||||||||||
Period Ended | % of | GAAP Results | Period Ended | % of | Period Ended | % of | GAAP Results | GAAP Results | Period Ended | % of | |||||||||||||||||||||||||||||||||||||
September 28, 2013 | Revenues | NeuCo (1) | September 28, 2013 | Revenues | September 29, 2012 | Revenues | Restructuring (3) | NeuCo (1) | September 29, 2012 | Revenues | |||||||||||||||||||||||||||||||||||||
Income (loss) from operations | $ | 13,058 | 6.4 | % | $ | 8 | $ | 13,050 | 6.6 | % | $ | 7,149 | 3.5 | % | $ | (6,340 | ) | $ | 406 | $ | 13,083 | 6.6 | % | ||||||||||||||||||||||||
Depreciation and amortization | 4,792 | 2.4 | % | 3 | 4,789 | 2.4 | % | 5,580 | 2.8 | % | 1,174 | 3 | 4,403 | 2.2 | % | ||||||||||||||||||||||||||||||||
EBITDA | 17,850 | 8.8 | % | 11 | 17,839 | 9.0 | % | 12,729 | 6.3 | % | (5,166 | ) | 409 | 17,486 | 8.8 | % | |||||||||||||||||||||||||||||||
Share-based compensation expenses | 2,153 | 1.1 | % | - | 2,153 | 1.1 | % | 3,790 | 1.9 | % | - | - | 3,790 | 1.9 | % | ||||||||||||||||||||||||||||||||
Amortization of forgivable loans | 9,764 | 4.8 | % | - | 9,764 | 4.9 | % | 4,492 | 2.2 | % | - | - | 4,492 | 2.3 | % | ||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 29,767 | 14.7 | % | $ | 11 | $ | 29,756 | 14.9 | % | $ | 21,011 | 10.4 | % | $ | (5,166 | ) | $ | 409 | $ | 25,768 | 13.0 | % | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
(1) These adjustments include activity related to NeuCo in the Company's GAAP results. | |||||||||||||||||||||||||||||||||||||||||||||||
(2) During the fiscal quarter ended September 29, 2012, the Company incurred pre-tax expenses of $4.4 million and related income tax benefit of $0.8 million principally associated with restructuring actions announced in the third quarter of fiscal 2012. These actions included the elimination and restructuring of selected practice areas, and reducing selling, general, and administrative costs. In connection with the restructuring plan, the Company eliminated its Chemicals practice and closed its Middle East operations. |
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
(3) During the fiscal year to date period ended September 29, 2012, the Company incurred pre-tax expenses of $6.3 million and related income tax benefit of $0.9 million principally associated with restructuring actions announced in the third quarter of fiscal 2012. Of these amounts, $4.4 million of pre-tax expenses and $0.8 million of related income tax benefit were in connection with restructuring activities announced in the third quarter of fiscal 2012. These actions included the elimination and restructuring of selected practice areas, and reducing selling, general, and administrative costs. In connection with the restructuring plan, the Company eliminated its Chemicals practice and closed its Middle East operations. In the first half of fiscal 2012, the Company also incurred pre-tax expenses of $1.9 million and related income tax provision of $44,000 in connection with the surrender of a portion of the Company's leased office space in London, England and adjustments related to its leased office space in Houston, TX. |
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|
CRA INTERNATIONAL, INC. | |||||||||||
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||
(In thousands) | |||||||||||
Fiscal Year to |
Fiscal Year to |
||||||||||
September 28, | September 29, | ||||||||||
2013 | 2012 | ||||||||||
Operating activities: | |||||||||||
Net income | $ | 7,519 | $ | 503 | |||||||
Adjustments to reconcile net income | |||||||||||
to net cash used in operating activities, | |||||||||||
net of effect of acquired businesses: | |||||||||||
Depreciation and amortization | 4,853 | 4,454 | |||||||||
Loss on disposal of property and equipment | - | 1,162 | |||||||||
Deferred rent | (1,594 | ) | (2,186 | ) | |||||||
Deferred income taxes | 357 | 320 | |||||||||
Share-based compensation expenses | 2,153 | 3,790 | |||||||||
Excess tax benefits from share-based compensation | (5 | ) | (38 | ) | |||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | (1,538 | ) | 12,015 | ||||||||
Unbilled services | (8,710 | ) | (9,994 | ) | |||||||
Prepaid expenses and other assets | (19,375 | ) | (9,410 | ) | |||||||
Accounts payable, accrued expenses and other liabilities | (1,840 | ) | (23,418 | ) | |||||||
Net cash used in operating activities | (18,180 | ) | (22,802 | ) | |||||||
Investing activities: | |||||||||||
Consideration relating to acquisitions, net | (15,591 | ) | - | ||||||||
Purchase of property and equipment | (2,497 | ) | (1,856 | ) | |||||||
Sale of investments | - | (9,494 | ) | ||||||||
Purchase of investments | - | 23,989 | |||||||||
Collections on notes receivable | 14 | 939 | |||||||||
Net cash provided by (used in) investing activities | (18,074 | ) | 13,578 | ||||||||
Financing activities: | |||||||||||
Issuance of common stock, principally stock option exercises | 207 | 575 | |||||||||
Payments on notes payable | (700 | ) | (650 | ) | |||||||
Borrowings under line of credit | 17,320 | - | |||||||||
Repayments under line of credit | (17,320 | ) | - | ||||||||
Tax withholding payments reimbursed by restricted shares | (227 | ) | (742 | ) | |||||||
Excess tax benefits from share-based compensation | 5 | 38 | |||||||||
Repurchase of common stock | (631 | ) | (9,062 | ) | |||||||
Net cash used in financing activities | (1,346 | ) | (9,841 | ) | |||||||
Effect of foreign exchange rates on cash and cash equivalents | 51 | (225 | ) | ||||||||
Net decrease in cash and cash equivalents | (37,549 | ) | (19,290 | ) | |||||||
Cash and cash equivalents at beginning of period | 55,451 | 61,587 | |||||||||
Cash and cash equivalents at end of period | $ | 17,902 | $ | 42,297 | |||||||
Supplemental cash flow information: | |||||||||||
Cash paid for income taxes | $ | 1,337 | $ | 8,724 | |||||||
Cash paid for interest | $ | 222 | $ | 167 |
Source:
Charles River Associates
Wayne D. Mackie, 617-425-3740
Executive Vice President, CFO
or
Sharon Merrill Associates, Inc.
Dennis Walsh, 617-542-5300
Vice President